[1]李 丽.米非司酮与乳酸依沙吖啶联合治疗中晚期妊娠引产的临床疗效[J].医学信息,2019,32(24):159-160163.[doi:10.3969/j.issn.1006-1959.2019.24.058]
　LI Li.Clinical Efficacy of Mifepristone Combined with Ethacridine Lactate in the Induction of Labor in Mid-to-late Pregnancy[J].Medical Information,2019,32(24):159-160163.[doi:10.3969/j.issn.1006-1959.2019.24.058]
点击复制

米非司酮与乳酸依沙吖啶联合治疗中晚期妊娠引产的临床疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年24期
页码:
159-160163
栏目:
药物与临床
出版日期:
2019-12-15

文章信息/Info

Title:
Clinical Efficacy of Mifepristone Combined with Ethacridine Lactate in the Induction of Labor in Mid-to-late Pregnancy
文章编号:
1006-1959（2019）24-0159-03
作者:
李 丽
（江西省赣县区妇幼保健院妇产科，江西 赣州 341000）
Author(s):
LI Li
(Department of Obstetrics and Gynecology,Ganxian Maternal and Child Health Hospital,Ganzhou 341000,Jiangxi,China)
关键词:
中晚期妊娠; 引产; 乳酸依沙吖啶; 米非司酮
Keywords:
Mid-late pregnancy; Induction of labor; Ethacridine lactate; Mifepristone
分类号:
R714
DOI:
10.3969/j.issn.1006-1959.2019.24.058
文献标志码:
A
摘要:
目的 探究米非司酮联合乳酸依沙吖啶在中晚期妊娠引产中的效果。方法 选择2018年1月~12月我院接收的44例中晚期妊娠引产孕妇为研究对象，采用随机数字表法分为对照组和研究组，各22例，对照组注射乳酸依沙吖引产，研究组在此基础上联合米非司酮引产，比较两组宫缩开始时间、引产时间、阴道出血量、引产成功率及并发症发生情况。结果 研究组宫缩开始时间、引产时间分别为（14.85±2.46）h、（30.10±4.96）h，短于对照组的（22.41±3.22）h、（43.98±5.14）h，差异有统计学意义（P＜0.05）；研究组阴道出血量为（89.21±10.36）ml，少于对照组的（145.05±16.95）ml，差异有统计学意义（P＜0.05）；研究组并发症发生率低于对照组，引产成功率高于对照组，差异均有统计学意义（P＜0.05）。结论 米非司酮联合乳酸依沙吖啶可缩短中晚期妊娠引产产妇宫缩时间及引产时间，可有效降低引产期间产妇阴道出血量及并发症发生率，引产成功率高，应用效果显著。
Abstract:
Objective To explore the effect of mifepristone combined with ethacridine lactate in induction of labor in mid-late pregnancy. Methods 44 mid-late pregnancy pregnant women who were induced by labor in our hospital from January to December 2018 were selected as study subjects. They were divided into control group and observation group by random number table method,with22 cases in each group. The control group was injected with ethacridine lactate to induce labor. Combined with mifepristone for induction of labor, the two groups were compared for the onset of uterine contraction, the time of induction of labor, the amount of vaginal bleeding, the success rate of induction of labor and the incidence of complications. Results The maternal contraction onset time and induction time in the study group were (14.85±2.46) h and (30.10±4.96) h, which were less than the control group’s (22.41±3.22) h and (43.98± 5.14) h,the differences were statistically significant(P＜0.05); the amount of vaginal bleeding in the study group was (89.21±10.36) ml, which was less than that in the control group (145.05±16.95) ml,the difference was statistically significant (P<0.05); the incidence of complications in the study group was lower than the control group had a higher rate of induction of labor than the control group,the difference was statistically significant (P<0.05). Conclusion Mifepristone combined with ethacridine lactate can shorten the contraction time and induction time of induction of labor in mid-to-late pregnancy. It can effectively reduce the amount of vaginal bleeding and the incidence of complications during induction of labor. The induction rate is high and the application effect is significant.

参考文献/References:

[1]游丽丽.探讨口服米非司酮配合乳酸依沙吖啶对中晚期妊娠引产的临床治疗效果[J].中外医学研究,2014,62(36):28-29.[2]张改莲.米非司酮联合乳酸依沙吖啶溶液治疗中期妊娠引产53例临床疗效[J].临床合理用药杂志,2015,95(2):98-99.[3]王敏,薛惠英.依沙吖啶联合米非司酮和米索前列醇治疗中期妊娠引产的疗效观察[J].现代药物与临床,2018,33(2):325-329.[4]翁俊英.米非司酮口服联合乳酸依沙吖啶注射液羊膜腔内注射在瘢痕子宫中期妊娠引产中的应用[J].河南医学研究,2019,28(10):1830-1831.[5]王娟,李洁,刘虹.米非司酮口服联合依沙吖啶羊膜腔注射对瘢痕子宫中期妊娠的引产效果及安全性评价[J].中国药业,2018,27(6):45-47.[6]张俊霞.单独乳酸依沙吖啶羊膜腔内注射或联合米非司酮中期引产的临床价值分析[J].实用妇科内分泌杂志(电子版), 2017, 4(8):59-60.[7]王金兰.疤痕子宫妊娠中期引产中联合应用乳酸依沙吖啶与米非司酮的效果[J].临床医药文献电子杂志,2016,3(57):11428.[8]杨微,刘润丽,杨卫霞.小剂量米非司酮联合依沙吖啶用于终止瘢痕子宫中期妊娠引产的疗效[J].黑龙江医药科学,2015,38(2):77-78.[9]侯祎,蔡玉娟,钟少平.利凡诺尔联合米非司酮用于瘢痕子宫晚期妊娠引产的疗效观察[J].浙江临床医学,2017,19(1):56-57.[10]陈小红,侍晓杰.米非司酮联合依沙吖啶用于疤痕子宫中期妊娠引产的有效性分析及研究[J].实用妇科内分泌杂志(电子版),2017,4(14):53-54.[11]徐素君,陈敏,陈立新,等.米非司酮配伍卡前列甲酯、乳酸依沙吖啶和水囊在瘢痕子宫中期妊娠引产中的可行性比较[J].中国性科学,2017,26(1):112-115.[12]吴志茹.米非司酮联合乳酸依沙吖啶治疗中晚期妊娠引产的效果分析[J].中外医学研究,2018,382(14):160-162.

相似文献/References:

[1]宋晓娟.缩宫素与COOK双球囊在促进宫颈成熟合并引产的临床对比研究[J].医学信息,2018,31(19):117.[doi:10.3969/j.issn.1006-1959.2018.19.035]
　SONG Xiao-juan.Clinical Comparative Study of Oxytocin and COOK Double Balloon in Promoting Cervical Ripening and Induction of Labor[J].Medical Information,2018,31(24):117.[doi:10.3969/j.issn.1006-1959.2018.19.035]
[2]程 芳,辛 婷,王满兰,等.宫颈球囊扩张术联合缩宫素在初产妇引产中的效果观察[J].医学信息,2022,35(20):71.[doi:10.3969/j.issn.1006-1959.2022.20.017]
　CHENG Fang,XIN Ting,WANG Man-lan,et al.Effect Observation of Cervical Balloon Dilatation Combined with Oxytocin in Induced Labor of Primipara[J].Medical Information,2022,35(24):71.[doi:10.3969/j.issn.1006-1959.2022.20.017]
[3]王 敏.宫颈扩张球囊与米索前列醇在足月妊娠初产妇促宫颈成熟引产中的效果比较[J].医学信息,2021,34(22):94.[doi:10.3969/j.issn.1006-1959.2021.22.028]
　WANG Min.Comparison of Cervical Dilation Balloon and Misoprostol in Promoting Cervical Ripening and Induction of Labor in Primiparae with Full-term Pregnancy[J].Medical Information,2021,34(24):94.[doi:10.3969/j.issn.1006-1959.2021.22.028]
[4]张志巧.宫颈扩张球囊与米索前列醇在足月妊娠初产妇促宫颈成熟引产中的临床疗效及安全性[J].医学信息,2021,34(24):99.[doi:10.3969/j.issn.1006-1959.2021.24.023]
　ZHANG Zhi-qiao.Clinical Efficacy and Safety of Cervical Dilation Balloon and Misoprostol in Promoting Cervical Ripening and Induction of Labor in Primiparae with Full-term Pregnancy[J].Medical Information,2021,34(24):99.[doi:10.3969/j.issn.1006-1959.2021.24.023]
[5]彭心钰,陈先侠.引产时机对非药物治疗妊娠期糖尿病母婴结局的影响[J].医学信息,2023,36(11):121.[doi:10.3969/j.issn.1006-1959.2023.11.024]
　PENG Xin-yu,CHEN Xian-xia.Effect of Different Timing of Labor Induction on Maternal and Infant Pregnancy Outcomes of Non Drug Treated Gestational Diabetes Mellitus[J].Medical Information,2023,36(24):121.[doi:10.3969/j.issn.1006-1959.2023.11.024]

更新日期/Last Update: 2019-12-15